| Dr Steven Howard Schneider, MD | |
|
70 Kenyon Ave, Suite 103, Wakefield, RI 02879-4239 | |
| (401) 789-0661 | |
| (401) 788-9358 |
| Full Name | Dr Steven Howard Schneider |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 70 Kenyon Ave, Wakefield, Rhode Island |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063421659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD12069 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South County Hospital Inc | Wakefield, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Silver Spring Health Care Management Inc | 4688661127 | 118 |
News Archive
A study conducted by HealthMedia, Inc. and Highmark Inc., published in the November/December edition of the American Journal of Health Promotion, proves that an online program offers a return on investment and enhances a patient's ability to self manage chronic health conditions.
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.
› Verified 5 days ago
| Entity Name | Silver Spring Health Care Management Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245246115 PECOS PAC ID: 4688661127 Enrollment ID: O20070125000408 |
News Archive
A study conducted by HealthMedia, Inc. and Highmark Inc., published in the November/December edition of the American Journal of Health Promotion, proves that an online program offers a return on investment and enhances a patient's ability to self manage chronic health conditions.
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Howard Schneider, MD 70 Kenyon Ave, Suite 103, Wakefield, RI 02879-4239 Ph: (401) 789-0661 | Dr Steven Howard Schneider, MD 70 Kenyon Ave, Suite 103, Wakefield, RI 02879-4239 Ph: (401) 789-0661 |
News Archive
A study conducted by HealthMedia, Inc. and Highmark Inc., published in the November/December edition of the American Journal of Health Promotion, proves that an online program offers a return on investment and enhances a patient's ability to self manage chronic health conditions.
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.
Personalized Immunotherapy for Tumor Diseases and Beyond introduces personalized immunotherapy with multi-dimensional models of analysis to determine the best plan for the immunotherapy of patients.
While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track disease and evaluate therapies, and these biomarkers may eventually be used as outcome measures in clinical trials. Biomarkers could be especially helpful to monitor changes during the time prior to diagnosis and appearance of overt symptomatology.
› Verified 5 days ago
Dr. Mary Christina Simpson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 155 Main St, Wakefield, RI 02879 Phone: 401-782-2400 | |
Robert T O'neill, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave Unit 215, Wakefield, RI 02879 Phone: 401-782-9900 | |
Joseph James O'neill, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave, Wakefield, RI 02879 Phone: 401-789-9210 Fax: 401-792-3699 | |
Andrew P Neuhauser, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 701-789-0661 Fax: 401-788-3958 | |
Megin L Dalton, M.D. Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 401-789-0661 Fax: 401-788-3958 | |
Kathleen Anne Cassin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 70 Kenyon Ave, Suite 103, Wakefield, RI 02879 Phone: 401-789-0661 Fax: 401-788-3958 |